In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Paper Diagnostics
... at a CAGR of 6.6% over the analysis period 2023-2030. Lateral Flow Assay Kits, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$6.7 Billion by the ... Read More
-
Heparin
... of 2.8% over the analysis period 2023-2030. Low Molecular Weight Heparin (LMWH), one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$5.9 Billion by the end of ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Multiplex Detection Immunoassays
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Disease Testing Application, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion ... Read More
-
Nucleic Acid Labeling
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 ... Read More
-
Oxidative Stress Assays
... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. ELISA Technology, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$673.6 Million by ... Read More
-
Coagulation / Hemostasis Analyzers
... reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and ... Read More
-
The Global Microfluidics Market 2025-2035
... to revolutionize traditional approaches to diagnostics, drug development, and process control. Medical applications currently dominate market share, with point-of-care diagnostics and pharmaceutical research leading growth, while industrial applications in environmental monitoring, food safety, and process ... Read More
-
Testing and Analysis Services
... 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Elemental Analysis, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.4 Billion by the ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2023-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.2 Billion by the end ... Read More
-
Rapid Medical Diagnostic Kits
... 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$10.7 ... Read More
-
Coagulation Factor Concentrates
... at a CAGR of 7.1% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$8.8 Billion by the ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.3% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2023-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
Glucose Biosensors
... at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Nucleic Acid Isolation and Purification
... is expected to reach US$12.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Nucleic Acid Isolation and Purification Kits, one of the segments analyzed in the report, is expected ... Read More
-
Coagulation Testing
... at a CAGR of 4.7% over the analysis period 2023-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the end ... Read More
-
Hemoglobin Testing
... at a CAGR of 5.6% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$3.0 Billion by the ... Read More
-
Histology and Cytology
... by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$50.6 Billion by the ... Read More
-
Oncology Molecular Diagnostics
... by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by ... Read More
-
Antithrombin
... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More
-
Therapeutic Plasma Exchange
... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Neurological Disorders Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million ... Read More
-
Thyroid Function Tests
... by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by ... Read More
-
Hepatitis Test Solution/Diagnosis
... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. ELISA, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.4 Billion by the ... Read More
-
In Vitro Toxicology Testing
... reach US$26.0 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. Cell Culture In Vitro Toxicology Testing, one of the segments analyzed in the report, is expected to record a ... Read More
Research Assistance
